Andrew Frutkin, MD, FACC, FSCAI is Board Certified in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Interventional Cardiology. He is a Fellow of the American College of Cardiology and also of the Society of Cardiac Angiography and Interventions.
Dr. Frutkin evaluates and treats people with all aspects of cardiovascular disease. He has specialized training in interventional cardiology to treat patients who have coronary artery disease, peripheral vascular disease, and structural heart disease. He has additional training in non-invasive imaging modalities of echocardiography, nuclear cardiology and CT angiography.
Dr. Frutkin attended Stanford University as a National Merit Scholar and David Starr Jordan Scholar and graduated with a Bachelor of Science with honors in biological sciences. He completed an internal medicine residency and cardiovascular disease fellowship at the University of Washington. While serving as faculty in the Cardiology Division at the University of Washington, he also engaged in a grant-supported research fellowship studying mechanisms of atherosclerosis and cardiovascular development using complex transgenic mouse models. Dr. Frutkin then completed additional clinical training and research in interventional cardiology at St. Luke’s Mid America Heart Institute in Kansas City, Missouri, an internationally recognized center in cardiac care and research. Dr. Frutkin has presented abstracts at major national meetings and has published manuscripts in preeminent scientific and medical journals. Dr. Frutkin remains engaged in research as a sub-investigator on a number of device trials and he teaches in the Eisenhower Medical Center residency programs.
“I was drawn to medicine through my fascination with molecular biology and my desire to have a meaningful impact on people’s lives,” says Dr. Frutkin. “As cardiologists, we have experienced tremendous success in rigorously testing these medical advances in large clinical trials and applying those that work to the greatest benefit of our patients. Our professional societies have been instrumental in synthesizing and collating this ever-growing body of knowledge into practice guidelines. I use my knowledge and expertise to apply these evidence-based guidelines on an individualized basis to best treat my patients.”
Dr. Frutkin and his colleagues have developed the multidisciplinary Eisenhower Heart Valve Clinic to evaluate and treat patients who have complex heart disease. “One of our greatest advances has been the development of minimally invasive, catheter-based means to replace or repair diseased heart valves,” explains Dr. Frutkin. “Traditionally, open cardiac surgery was the only solution for patients who had diseased heart valves. However, some patients have been too ill or frail to undergo surgery safely. Now, new technology enables us to implant a new, prosthetic aortic valve or to repair a mitral valve in a patient’s failing heart through minimally invasive means, providing an effective and safer alternative to surgery for our most ill patients."
“I find the practice of cardiology enormously stimulating and rewarding,” says Dr. Frutkin. “I am privileged to be able to help people at their time of greatest need. But, I also value greatly the opportunity to sit down with patients in clinic and discuss their medical condition, diagnostic plan, and course of therapy. I strive for my patients to be fully-informed and educated so that they may make the right decisions that lead to a better lifestyle and health.”